{"id":2661,"date":"2025-07-24T13:25:13","date_gmt":"2025-07-24T11:25:13","guid":{"rendered":"https:\/\/connected-pathology.com\/?p=2661"},"modified":"2025-07-24T13:30:20","modified_gmt":"2025-07-24T11:30:20","slug":"connected-pathology-innoser-and-poulpharm-announce-strategic-partnership-to-expand-preclinical-and-histopathology-services","status":"publish","type":"post","link":"https:\/\/connected-pathology.com\/?p=2661","title":{"rendered":"Connected-Pathology, InnoSer, and Poulpharm Announce Strategic Partnership to Expand Preclinical and Histopathology Services\u00a0"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.20.2&#8243; _module_preset=&#8221;default&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.20.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.20.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.20.2&#8243; _module_preset=&#8221;default&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p style=\"text-align: center;\"><i><span data-contrast=\"auto\">Together, the partners aim to enable seamless access to integrated multi-species expertise, focusing on advanced preclinical drug development and automated histopathology services, streamlining preclinical research for both human and veterinary drug development.\u00a0<\/span><\/i><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><b><span data-contrast=\"auto\">Diepenbeek and Izegem, Belgium, July 24th, 2025 \u2013 <\/span><\/b><span data-contrast=\"auto\">Conntected-Pathology, a contract research organization (CRO) specialized in advanced digital histopathology; InnoSer,<\/span><span data-contrast=\"auto\"> a preclinical CRO; and Poulpharm, a CRO with expertise in microbiology and preclinical veterinary research, join forces to deliver integrated preclinical services tailored for both veterinary and human healthcare research. <\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><span data-contrast=\"auto\">This strategic partnership is designed to enhance the preclinical capabilities of each partner, including advanced drug development and histopathology services. By aligning their complementary strengths, InnoSer and Poulpharm, through Connected-Pathology, will provide seamless preclinical support by integrating multi-species expertise, advanced digital histopathology, and streamlined workflows, accelerating research timelines.\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><b><span data-contrast=\"auto\">This strategic collaboration combines:\u00a0\u00a0<\/span><\/b><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"2\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Connected-Pathology\u2019s advanced histopathology and digital pathology services, expanding its scope into multi-species and translational studies<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"2\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">InnoSer\u2019s translational research platforms and preclinical drug development capabilities<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"2\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"3\" data-aria-level=\"1\"><span data-contrast=\"auto\">Poulpharm\u2019s applied expertise in preclinical multi-species research and diagnostic services<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><b><span data-contrast=\"auto\">By working strategically together, the three partners aim to:<\/span><\/b><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"1\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Provide seamless access to larger animal models and multi-species expertise, enabling faster, more informed and translational drug development<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"1\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">Deliver high-throughput histopathology services including IHC, IF, ISH, and AI-supported image and biomarker analysis across multiple study types\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul style=\"text-align: justify;\">\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"1\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"3\" data-aria-level=\"1\"><span data-contrast=\"auto\">Provide end-to-end study support, from in vivo research to digital pathology and regulatory reporting<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\"><\/span><\/li>\n<\/ul>\n<p><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\"><\/span><\/p>\n<p style=\"text-align: justify;\"><span data-contrast=\"auto\">&#8220;This partnership reflects our shared vision to deliver smarter, more connected research services,&#8221; said <strong>Maarten De Gussem, DVM, Manager and veterinarian at Poulpharm.<\/strong> Together, we are building a stronger, innovation-driven foundation for translational research.&#8221;\u00a0 <\/span><\/p>\n<blockquote>\n<p style=\"text-align: justify;\"><\/blockquote>\n<p style=\"text-align: justify;\"><span data-contrast=\"auto\">\u201cThis partnership allows Connected-Pathology to extend its advanced digital histopathology solutions into broader preclinical applications across multiple species and diverse study types, significantly enhancing the depth and flexibility of our service offerings,\u201d said <strong>Wim Tiest, manager at Connected-Pathology.\u00a0<\/strong><\/span><\/p>\n<blockquote>\n<p style=\"text-align: justify;\"><\/blockquote>\n<p style=\"text-align: justify;\"><span data-contrast=\"auto\"><strong>Kris Motmans, PhD, CEO of InnoSer<\/strong>, further adds, &#8220;The combined strengths of Poulpharm\u2019s multi-species preclinical capabilities, InnoSer\u2019s advanced drug development platform, and Connected-Pathology\u2019s state-of-the-art histopathology services empower us to deliver seamless, integrated research solutions that accelerate drug development pipelines.\u201d<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><span data-contrast=\"auto\">The collaboration ensures clients benefit from faster timelines, deeper insights, and seamlessly connected pathology and laboratory workflows \u2014 supporting the next generation of preclinical drug development.\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><b><span data-contrast=\"auto\">About Connected-Pathology:<\/span><\/b><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><span data-contrast=\"auto\">Founded in 2021, Connected-Pathology allows CRO\u2019s, biotechs, pharmaceutical companies, and academic organizations to focus on understanding the complexities of their research and less on the operations. We offer end-to-end histopathology assessments and a flexible workflow that allows our customers to outsource the service and support level needed. This workflow is built with cost-effective and reliable channels that are digitized, automated, and efficient, such as our TxConnect track-and-trace ordering system combined with AI assessment tools.\u00a0\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/connected-pathology.com\/\"><span data-contrast=\"none\">www.connected-pathology.com<\/span><\/a><span data-contrast=\"auto\">\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\"><\/span><\/p>\n<p style=\"text-align: justify;\"><b><span data-contrast=\"auto\">About InnoSer:<\/span><\/b><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><span data-contrast=\"auto\">Founded in 2012, InnoSer is an innovative and dynamic CRO supporting the pre-clinical development of drugs from its facilities in Belgium and the Netherlands. InnoSer supports its customers in the critical steps of their drug development journey with well-characterized in vitro and in vivo disease models in addition to general drug development services, allowing to uncover valuable insights into the mode of action, pharmacokinetics, safety, and efficacy of investigational compounds.\u00a0\u00a0\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/www.innoserlaboratories.com\/\"><span data-contrast=\"none\">www.innoserlaboratories.com<\/span><\/a><span data-contrast=\"auto\">\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><b><span data-contrast=\"auto\">About Poulpharm: <\/span><\/b><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><span data-contrast=\"auto\">Founded in 2006 and headquartered in Izegem, Belgium, Poulpharm is a trusted CRO providing high-quality research services in animal health. With a global presence in Europe and Asia, we operate under GCP and GLP standards across diagnostics, (pre-)clinical trials, and safety studies. Our diagnostic portfolio includes bacteriology, virology, molecular techniques, parasitology, haematology, histology, and bio-analytics, supporting accurate disease detection and treatment. Poulpharm conducts contract research on feed additives, vaccines, and veterinary drugs, using validated models for parasitic, bacterial, and viral diseases. Our end-to-end support helps clients move from concept to market with confidence. Poulpharm is your independent partner for innovation, compliance, and animal health excellence.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><a href=\"http:\/\/www.poulpharm.com\/\"><span data-contrast=\"none\">www.poulpharm.com<\/span><\/a><span data-contrast=\"auto\">\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Together, the partners aim to enable seamless access to integrated multi-species expertise, focusing on advanced preclinical drug development and automated histopathology services, streamlining preclinical research for both human and veterinary drug development.\u00a0\u00a0 \u00a0 Diepenbeek and Izegem, Belgium, July 24th, 2025 \u2013 Conntected-Pathology, a contract research organization (CRO) specialized in advanced digital histopathology; InnoSer, a preclinical [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":2672,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-2661","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Connected-Pathology, InnoSer, and Poulpharm Announce Strategic Partnership to Expand Preclinical and Histopathology Services\u00a0 - Connected-Pathology<\/title>\n<meta name=\"description\" content=\"Together, the partners aim to enable seamless access to integrated multi-species expertise, focusing on advanced preclinical drug development and automated histopathology services, streamlining preclinical research for both human and veterinary drug development.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/connected-pathology.com\/?p=2661\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Connected-Pathology, InnoSer, and Poulpharm Announce Strategic Partnership to Expand Preclinical and Histopathology Services\u00a0 - Connected-Pathology\" \/>\n<meta property=\"og:description\" content=\"Together, the partners aim to enable seamless access to integrated multi-species expertise, focusing on advanced preclinical drug development and automated histopathology services, streamlining preclinical research for both human and veterinary drug development.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/connected-pathology.com\/?p=2661\" \/>\n<meta property=\"og:site_name\" content=\"Connected-Pathology\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-24T11:25:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-24T11:30:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/connected-pathology.com\/wp-content\/uploads\/2025\/07\/Veterinary-dermatopathology-blogcover.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"vermis_admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"vermis_admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/connected-pathology.com\\\/?p=2661#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/connected-pathology.com\\\/?p=2661\"},\"author\":{\"name\":\"vermis_admin\",\"@id\":\"https:\\\/\\\/connected-pathology.com\\\/#\\\/schema\\\/person\\\/b92a23d247445a9c4a448b0c476a675a\"},\"headline\":\"Connected-Pathology, InnoSer, and Poulpharm Announce Strategic Partnership to Expand Preclinical and Histopathology Services\u00a0\",\"datePublished\":\"2025-07-24T11:25:13+00:00\",\"dateModified\":\"2025-07-24T11:30:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/connected-pathology.com\\\/?p=2661\"},\"wordCount\":748,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/connected-pathology.com\\\/?p=2661#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/connected-pathology.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/Veterinary-dermatopathology-blogcover.png\",\"articleSection\":[\"news\"],\"inLanguage\":\"en\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/connected-pathology.com\\\/?p=2661#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/connected-pathology.com\\\/?p=2661\",\"url\":\"https:\\\/\\\/connected-pathology.com\\\/?p=2661\",\"name\":\"Connected-Pathology, InnoSer, and Poulpharm Announce Strategic Partnership to Expand Preclinical and Histopathology Services\u00a0 - Connected-Pathology\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/connected-pathology.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/connected-pathology.com\\\/?p=2661#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/connected-pathology.com\\\/?p=2661#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/connected-pathology.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/Veterinary-dermatopathology-blogcover.png\",\"datePublished\":\"2025-07-24T11:25:13+00:00\",\"dateModified\":\"2025-07-24T11:30:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/connected-pathology.com\\\/#\\\/schema\\\/person\\\/b92a23d247445a9c4a448b0c476a675a\"},\"description\":\"Together, the partners aim to enable seamless access to integrated multi-species expertise, focusing on advanced preclinical drug development and automated histopathology services, streamlining preclinical research for both human and veterinary drug development.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/connected-pathology.com\\\/?p=2661#breadcrumb\"},\"inLanguage\":\"en\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/connected-pathology.com\\\/?p=2661\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en\",\"@id\":\"https:\\\/\\\/connected-pathology.com\\\/?p=2661#primaryimage\",\"url\":\"https:\\\/\\\/connected-pathology.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/Veterinary-dermatopathology-blogcover.png\",\"contentUrl\":\"https:\\\/\\\/connected-pathology.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/Veterinary-dermatopathology-blogcover.png\",\"width\":1200,\"height\":628},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/connected-pathology.com\\\/?p=2661#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/connected-pathology.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Connected-Pathology, InnoSer, and Poulpharm Announce Strategic Partnership to Expand Preclinical and Histopathology Services\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/connected-pathology.com\\\/#website\",\"url\":\"https:\\\/\\\/connected-pathology.com\\\/\",\"name\":\"Connected-Pathology\",\"description\":\"Preclinical digital pathology\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/connected-pathology.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/connected-pathology.com\\\/#\\\/schema\\\/person\\\/b92a23d247445a9c4a448b0c476a675a\",\"name\":\"vermis_admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c100b5d6724aec02b6c235463b6f4a9d1984515a0e8ea4db6923fcb0e48692a5?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c100b5d6724aec02b6c235463b6f4a9d1984515a0e8ea4db6923fcb0e48692a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c100b5d6724aec02b6c235463b6f4a9d1984515a0e8ea4db6923fcb0e48692a5?s=96&d=mm&r=g\",\"caption\":\"vermis_admin\"},\"url\":\"https:\\\/\\\/connected-pathology.com\\\/?author=7\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Connected-Pathology, InnoSer, and Poulpharm Announce Strategic Partnership to Expand Preclinical and Histopathology Services\u00a0 - Connected-Pathology","description":"Together, the partners aim to enable seamless access to integrated multi-species expertise, focusing on advanced preclinical drug development and automated histopathology services, streamlining preclinical research for both human and veterinary drug development.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/connected-pathology.com\/?p=2661","og_locale":"en_US","og_type":"article","og_title":"Connected-Pathology, InnoSer, and Poulpharm Announce Strategic Partnership to Expand Preclinical and Histopathology Services\u00a0 - Connected-Pathology","og_description":"Together, the partners aim to enable seamless access to integrated multi-species expertise, focusing on advanced preclinical drug development and automated histopathology services, streamlining preclinical research for both human and veterinary drug development.","og_url":"https:\/\/connected-pathology.com\/?p=2661","og_site_name":"Connected-Pathology","article_published_time":"2025-07-24T11:25:13+00:00","article_modified_time":"2025-07-24T11:30:20+00:00","og_image":[{"width":1200,"height":628,"url":"https:\/\/connected-pathology.com\/wp-content\/uploads\/2025\/07\/Veterinary-dermatopathology-blogcover.png","type":"image\/png"}],"author":"vermis_admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"vermis_admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/connected-pathology.com\/?p=2661#article","isPartOf":{"@id":"https:\/\/connected-pathology.com\/?p=2661"},"author":{"name":"vermis_admin","@id":"https:\/\/connected-pathology.com\/#\/schema\/person\/b92a23d247445a9c4a448b0c476a675a"},"headline":"Connected-Pathology, InnoSer, and Poulpharm Announce Strategic Partnership to Expand Preclinical and Histopathology Services\u00a0","datePublished":"2025-07-24T11:25:13+00:00","dateModified":"2025-07-24T11:30:20+00:00","mainEntityOfPage":{"@id":"https:\/\/connected-pathology.com\/?p=2661"},"wordCount":748,"commentCount":0,"image":{"@id":"https:\/\/connected-pathology.com\/?p=2661#primaryimage"},"thumbnailUrl":"https:\/\/connected-pathology.com\/wp-content\/uploads\/2025\/07\/Veterinary-dermatopathology-blogcover.png","articleSection":["news"],"inLanguage":"en","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/connected-pathology.com\/?p=2661#respond"]}]},{"@type":"WebPage","@id":"https:\/\/connected-pathology.com\/?p=2661","url":"https:\/\/connected-pathology.com\/?p=2661","name":"Connected-Pathology, InnoSer, and Poulpharm Announce Strategic Partnership to Expand Preclinical and Histopathology Services\u00a0 - Connected-Pathology","isPartOf":{"@id":"https:\/\/connected-pathology.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/connected-pathology.com\/?p=2661#primaryimage"},"image":{"@id":"https:\/\/connected-pathology.com\/?p=2661#primaryimage"},"thumbnailUrl":"https:\/\/connected-pathology.com\/wp-content\/uploads\/2025\/07\/Veterinary-dermatopathology-blogcover.png","datePublished":"2025-07-24T11:25:13+00:00","dateModified":"2025-07-24T11:30:20+00:00","author":{"@id":"https:\/\/connected-pathology.com\/#\/schema\/person\/b92a23d247445a9c4a448b0c476a675a"},"description":"Together, the partners aim to enable seamless access to integrated multi-species expertise, focusing on advanced preclinical drug development and automated histopathology services, streamlining preclinical research for both human and veterinary drug development.","breadcrumb":{"@id":"https:\/\/connected-pathology.com\/?p=2661#breadcrumb"},"inLanguage":"en","potentialAction":[{"@type":"ReadAction","target":["https:\/\/connected-pathology.com\/?p=2661"]}]},{"@type":"ImageObject","inLanguage":"en","@id":"https:\/\/connected-pathology.com\/?p=2661#primaryimage","url":"https:\/\/connected-pathology.com\/wp-content\/uploads\/2025\/07\/Veterinary-dermatopathology-blogcover.png","contentUrl":"https:\/\/connected-pathology.com\/wp-content\/uploads\/2025\/07\/Veterinary-dermatopathology-blogcover.png","width":1200,"height":628},{"@type":"BreadcrumbList","@id":"https:\/\/connected-pathology.com\/?p=2661#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/connected-pathology.com\/"},{"@type":"ListItem","position":2,"name":"Connected-Pathology, InnoSer, and Poulpharm Announce Strategic Partnership to Expand Preclinical and Histopathology Services\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/connected-pathology.com\/#website","url":"https:\/\/connected-pathology.com\/","name":"Connected-Pathology","description":"Preclinical digital pathology","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/connected-pathology.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en"},{"@type":"Person","@id":"https:\/\/connected-pathology.com\/#\/schema\/person\/b92a23d247445a9c4a448b0c476a675a","name":"vermis_admin","image":{"@type":"ImageObject","inLanguage":"en","@id":"https:\/\/secure.gravatar.com\/avatar\/c100b5d6724aec02b6c235463b6f4a9d1984515a0e8ea4db6923fcb0e48692a5?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c100b5d6724aec02b6c235463b6f4a9d1984515a0e8ea4db6923fcb0e48692a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c100b5d6724aec02b6c235463b6f4a9d1984515a0e8ea4db6923fcb0e48692a5?s=96&d=mm&r=g","caption":"vermis_admin"},"url":"https:\/\/connected-pathology.com\/?author=7"}]}},"_links":{"self":[{"href":"https:\/\/connected-pathology.com\/index.php?rest_route=\/wp\/v2\/posts\/2661","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/connected-pathology.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/connected-pathology.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/connected-pathology.com\/index.php?rest_route=\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/connected-pathology.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2661"}],"version-history":[{"count":13,"href":"https:\/\/connected-pathology.com\/index.php?rest_route=\/wp\/v2\/posts\/2661\/revisions"}],"predecessor-version":[{"id":2676,"href":"https:\/\/connected-pathology.com\/index.php?rest_route=\/wp\/v2\/posts\/2661\/revisions\/2676"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/connected-pathology.com\/index.php?rest_route=\/wp\/v2\/media\/2672"}],"wp:attachment":[{"href":"https:\/\/connected-pathology.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2661"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/connected-pathology.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2661"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/connected-pathology.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2661"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}